Kane Logo Cropped TransBG.png
Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel
27 nov. 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces today that BioStem Technologies Inc....
Kane Logo Cropped TransBG.png
Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel
14 nov. 2024 13h10 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Agreement to Acquire FB Dermatology
12 nov. 2024 13h08 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that it has entered into a binding term sheet (the...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine
23 oct. 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it is donating 2,000 ounces of revyve™ Antimicrobial Wound...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Exclusive Distribution Agreement With XSONX
17 oct. 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution...
Kane Logo Cropped TransBG.png
Kane Biotech to Participate in a Multinational Corporate Collaboration Project
03 oct. 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and up to...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Attendance at Upcoming Wound Care Conferences
26 sept. 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its revyve™...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Second Quarter 2024 Financial Results
29 août 2024 16h15 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its second quarter 2024 financial results....
Kane Logo Cropped TransBG.png
Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations
29 août 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the publication of a new review article on DispersinB® in the...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel
28 août 2024 08h40 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has signed a three year distribution...